Home / Going-concern warnings / Lexaria Bioscience Corp.
Filed 2025-07-14 路 Form 10-Q 路 Accession 0001640334-25-001195 nano
Price before filing: $13.21 (2025-07-11 close, split/dividend-adjusted)
Market cap at flag: $16.3M (2025-07-14) 路 Latest: $4.7M (2026-10-16)
| Window | LEXX | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -5.8% | +3.4% | -9.2% | 2025-08-13 |
| 90 days | +2.6% | +6.6% | -4.0% | 2025-10-13 |
| 180 days | -12.6% | +12.1% | -24.7% | 2026-01-12 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: 5 insiders bought $49K (6 purchases)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-07-14: red flag filed | |||||||
| 2025-07-29 | BUNKA CHRISTOPHER Director | Purchase | 15,600 | $0.92 | $14K | no | Form 4 |
| 2025-07-29 | CHRISTOPHER RICHARD Chief Executive Officer, Director | Purchase | 15,000 | $0.91 | $14K | no | Form 4 |
| 2025-07-29 | Carle Vanessa Secretary | Purchase | 750 | $0.91 | $682 | no | Form 4 |
| 2025-07-29 | DOCHERTY JOHN MARTIN President & CSO, Director | Purchase | 5,376 | $0.93 | $5K | no | Form 4 |
| 2025-07-29 | McKechnie William Edward Director | Purchase | 5,000 | $0.91 | $5K | no | Form 4 |
| 2025-07-30 | BUNKA CHRISTOPHER Director | Purchase | 11,900 | $0.91 | $11K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-04-15 to 2025-08-13. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"The recurring losses and negative net cash flows raise substantial doubt as to the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-05-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.